Literature DB >> 21998006

Prevention and treatment of MS: studying the effects of vitamin D.

Kassandra L Munger1, Alberto Ascherio.   

Abstract

Observational studies suggest that adequate vitamin D nutrition may reduce the risk of MS and affect the course of the disease. Inherent limitations in these studies, however, preclude a causal interpretation. Randomized controlled clinical trials are the next step to addressing whether vitamin D prevents MS or can favorably affect the course and progression of MS. Here we briefly review the current literature on vitamin D and MS, both as a risk factor and potential treatment for MS with a focus on the issues and challenges in designing prevention and treatment clinical trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998006      PMCID: PMC3351202          DOI: 10.1177/1352458511425366

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  35 in total

1.  Effects of seasons on magnetic resonance imaging--measured disease activity in patients with multiple sclerosis.

Authors:  M Rovaris; G Comi; M P Sormani; J S Wolinsky; D Ladkani; M Filippi
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

2.  Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

Authors:  D P Auer; E M Schumann; T Kümpfel; C Gössl; C Trenkwalder
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

3.  Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.

Authors:  Stephanie Knippenberg; Joost Smolders; Mariëlle Thewissen; Evelyn Peelen; Jan Willem Cohen Tervaert; Raymond Hupperts; Jan Damoiseaux
Journal:  Mult Scler       Date:  2011-06-20       Impact factor: 6.312

4.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study.

Authors:  E Hyppönen; E Läärä; A Reunanen; M R Järvelin; S M Virtanen
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

5.  Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

Authors:  P Goldberg; M C Fleming; E H Picard
Journal:  Med Hypotheses       Date:  1986-10       Impact factor: 1.538

6.  Seasonal variation of multiple sclerosis exacerbations in Japan.

Authors:  G Ogawa; H Mochizuki; M Kanzaki; K Kaida; K Motoyoshi; K Kamakura
Journal:  Neurol Sci       Date:  2004-02       Impact factor: 3.307

7.  Seasonal variation of multiple sclerosis exacerbations in Arizona.

Authors:  C R Bamford; W A Sibley; C Thies
Journal:  Neurology       Date:  1983-06       Impact factor: 9.910

8.  Vitamin D intake and incidence of multiple sclerosis.

Authors:  K L Munger; S M Zhang; E O'Reilly; M A Hernán; M J Olek; W C Willett; A Ascherio
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

9.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study.

Authors:  I A F van der Mei; A-L Ponsonby; T Dwyer; L Blizzard; R Simmons; B V Taylor; H Butzkueven; T Kilpatrick
Journal:  BMJ       Date:  2003-08-09

10.  Cytokine profile in patients with multiple sclerosis following vitamin D supplementation.

Authors:  B D Mahon; S A Gordon; J Cruz; F Cosman; M T Cantorna
Journal:  J Neuroimmunol       Date:  2003-01       Impact factor: 3.478

View more
  22 in total

Review 1.  Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review.

Authors:  Abbey R Tredinnick; Yasmine C Probst
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 2.  Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.

Authors:  Linda Rolf; Anne-Hilde Muris; Raymond Hupperts; Jan Damoiseaux
Journal:  Immunology       Date:  2016-02-02       Impact factor: 7.397

3.  Low testosterone is associated with disability in men with multiple sclerosis.

Authors:  R Bove; A Musallam; B C Healy; K Raghavan; B I Glanz; R Bakshi; H Weiner; P L De Jager; K K Miller; T Chitnis
Journal:  Mult Scler       Date:  2014-04-07       Impact factor: 6.312

Review 4.  Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.

Authors:  Kelly C Simon; Kassandra L Munger; Alberto Ascherio
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

5.  Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.

Authors:  Charles Pierrot-Deseilligny; Sophie Rivaud-Péchoux; Pierre Clerson; Raphaël de Paz; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

6.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

7.  The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.

Authors:  Riley Bove; Muhammed T Malik; Camilo Diaz-Cruz; Alicia Chua; Taylor J Saraceno; David Bargiela; Emily Greeke; Bonnie I Glanz; Brian C Healy; Tanuja Chitnis
Journal:  Neurology       Date:  2015-09-04       Impact factor: 9.910

8.  What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?

Authors:  Linn H Steffensen; Magritt Brustad; Margitta T Kampman
Journal:  J Neurol       Date:  2012-08-01       Impact factor: 4.849

Review 9.  Dendritic cells and multiple sclerosis: disease, tolerance and therapy.

Authors:  Mohammad G Mohammad; Masoud Hassanpour; Vicky W W Tsai; Hui Li; Marc J Ruitenberg; David W Booth; Jordi Serrats; Prue H Hart; Geoffrey P Symonds; Paul E Sawchenko; Samuel N Breit; David A Brown
Journal:  Int J Mol Sci       Date:  2012-12-27       Impact factor: 5.923

Review 10.  B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies.

Authors:  Maria T Cencioni; Miriam Mattoscio; Roberta Magliozzi; Amit Bar-Or; Paolo A Muraro
Journal:  Nat Rev Neurol       Date:  2021-06-01       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.